FDA Issues Guidelines For Security Of Medical Devices In UseFDA Issues Guidelines For Security Of Medical Devices In Use
Guidance advises manufacturers on how to continue monitoring the devices once they are sold.
January 4, 2017
The US Food and Drug Administration (FDA) has issued guidelines on post-market cybersecurity monitoring of medical devices as a follow-up to the 2014 pre-market guidance, Information Security Media Group (ISMG) reports.
The FDA's guidelines are voluntary, and outline steps for manufacturers to continue ensuring cybersecurity of the devices after marketing and improving critical infrastructure cybersecurity via the National Institute of Standards and Technology standards.
The guidance comes in the wake of the recent controversy surrounding allegations by Muddy Waters Capital and MedSec Holdings that pacemaker devices manufactured by St. Jude Medical had cybersecurity flaws.
"Central to these recommendations is FDA's belief that medical device manufacturers should implement a structured and comprehensive program to manage cybersecurity risks," says FDA’s Suzanne Schwartz, adding the agency will continue to work on providing further advisories when needed.
Kevin Fu of Virta Laboratories said the guidance "responds to many of the medical device security issues highlighted in reports by the National Academies and the NIST Information Security and Privacy Advisory Board over the last six years."
Read more here.
About the Author(s)
You May Also Like
Hacking Your Digital Identity: How Cybercriminals Can and Will Get Around Your Authentication MethodsOct 26, 2023
Modern Supply Chain Security: Integrated, Interconnected, and Context-DrivenNov 06, 2023
How to Combat the Latest Cloud Security ThreatsNov 06, 2023
Reducing Cyber Risk in Enterprise Email Systems: It's Not Just Spam and PhishingNov 01, 2023
SecOps & DevSecOps in the CloudNov 06, 2023